Showing results (1-10 of 320) with videos related to
Sort By:
Pageof 32
Future Oncology (London, England)|February 7, 2007
Alemtuzumab in chronic lymphocytic leukemiaDanelle F James, Thomas J KippsAdvances in Therapy|July 5, 2011
Rituximab in chronic lymphocytic leukemiaDanelle F James, Thomas J KippsEuropean Journal of Haematology|February 18, 2011
Analysis of CLLU1 expression levels before and after therapy in patients with chronic lymphocytic leukemiaAnne Mette Buhl, Danelle F James, Donna Neuberg, et al.Blood|September 16, 2006
BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathwayTomoyuki Endo, Mitsufumi Nishio, Thomas Enzler, et al.Leukemia Research|February 21, 2021
Impact of long-term ibrutinib treatment on circulating immune cells in previously untreated chronic lymphocytic leukemiaIsabelle G Solman, Lisa K Blum, Jan A Burger, et al.Leukemia & Lymphoma|October 3, 2018
Characterizing the kinetics of lymphocytosis in patients with chronic lymphocytic leukemia treated with single-agent ibrutinibJacqueline C Barrientos, Jan A Burger, John C Byrd, et al.Cancer Journal (Sudbury, Mass.)|August 16, 2021
Mining the Microenvironment for Therapeutic Targets in Chronic Lymphocytic LeukemiaThomas J KippsSeminars in Oncology|February 14, 2002
Advances in classification and therapy of indolent B-cell malignanciesThomas J KippsSeminars in Oncology|February 1, 2017
Advances in classification and therapy of indolent B-cell malignanciesThomas J KippsCurrent Opinion in Hematology|June 12, 2003
Immunobiology of chronic lymphocytic leukemiaThomas J KippsPageof 32